Base funding

The CHILD Study received base funding from the Allergy, Genes and Environment Network of Centres of Excellence (AllerGen NCE) and the Canadian Institutes of Health Research (CIHR), in the sum of $6 million each, for a total of $12 million, over 6 years.

ag-logo cihr_logo_

Beyond this base funding, the CHILD Study has received continuing support from AllerGen in the form of research and special initiatives funding, and from CIHR in the form of project and team grants. These CIHR grants are listed in the CHILD grants database, referenced below.

Funding partners
  • Alberta Health Services
  • BC Children’s Hospital
  • Boehringer Ingelheim
  • Canada Mortgage and Housing Corporation (CMHC)
  • Childhood Asthma Foundation
  • Children’s Hospital Research Institute of Manitoba
  • Environment Canada
  • GlaxoSmithKline
  • Health Canada
  • Healthy Child Manitoba
  • Research Manitoba
  • Roche Ltd.
  • SickKids Foundation
  • SickKids Research Institute
  • St. Joseph’s Hospital Foundation
  • The Centre for Understanding & Preventing Infection in Children
  • The Manitoba Developmental Origins of Chronic Diseases in Children Network (DEVOTION)
  • The University of British Columbia, Department of Pediatrics, Division of Infectious Diseases
  • University of Manitoba, Rady Faculty of Medicine
  • University of Toronto McLaughlin Centre
  • Women & Children’s Health Research Institute
GRANT FUNDING

Specific, focused research initiatives within the CHILD Study have been funded by grants, of varying amounts and with varying timelines, sourced from diverse granting agencies, as detailed in the CHILD Grants database.